BERLIN, March 3 (Reuters) – Swiss pharmaceutical company ​Roche (ROG.S), opens new tab is aiming ‌for a double-digit market share in ​the weight ​loss market and wants ⁠to close ​the gap on ​its Danish rival Novo Nordisk (NOVOb.CO), opens new tab, its CEO told ​Germany’s Handelsblatt ​business daily.

“We expect to ‌be ⁠among the top three in the market at ​the ​very ⁠least,” Roche Chief Executive ​Thomas Schinecker said ​in ⁠an interview with the newspaper ⁠published ​on ​Tuesday.

Sign up here.

Writing by Linda Pasquini; Editing ​by Christopher Cushing

Our Standards: The Thomson Reuters Trust Principles., opens new tab

Purchase Licensing Rights